FDA approves new antibiotic for complicated urinary tract infections
The Food and Drug Administration yesterday an antibacterial drug to treat adults with complicated urinary tract infections, including kidney infections caused by susceptible gram-negative microorganisms who have limited or no alternative treatment options. The drug’s labeling includes a warning regarding a higher all-cause mortality rate observed in patients treated with the new drug compared to those treated with other antibiotics in a trial involving critically ill patients with multidrug-resistant gram-negative bacterial infections.
Related News Articles
Headline
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community HealthVickie Johnson, executive vice president and chief community officer at…
Headline
As part of Community Health Improvement Week June 9-13, two experts from Corewell Health share how an impactful health care ecosystem model is supporting local…
Headline
With June 9-13 being Community Health Improvement Week, three experts from HonorHealth discuss how the health care network is addressing community needs beyond…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…
Headline
Zaira Khalid, M.D., senior staff geriatric psychiatrist at Henry Ford Behavioral Health Hospital, discusses the unique physical, emotional and social needs of…